[1] |
陈小平,毛节明,郭静萱,等.脂蛋白(a)与冠状动脉病变[J].中华心血管病杂志,2002,30(10):589. |
[2] |
KOENIG W,TWARDELLA D,BRENNER H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events:more than simply a marker of glomerular filtration rate[J].Clin Chem,2005,51(2):321. |
[3] |
NAGESH CM,ROY A.Role of biomarkers in risk stratification of acute coronary syndrome[J].Indian J Med Res,2010,132:627. |
[4] |
GENSINI GG.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51(6):606. |
[5] |
杨惠月,边云飞,李小雷,等.青年冠心病患者临床危险因素分析[J].山西医科大学学报,2015,46(5):396. |
[6] |
孙乙铭.老年肺源性心脏病合并冠心病患者的相关因素分析[J].临床合理用药杂志,2015,8(12):86. |
[7] |
LIBBY P.Inflammation in atheronsclerosis[J].Arterioscler Thromb Vasc Biol,2012,32(9):2045. |
[8] |
AFANAS'EVA OI,KLESAREVA EA,LEVASHEV PA,et al.Autoantibodies against lipoprotein(a) in patients with coronary heart disease[J].Kardiologiia,2014,54(6):4. |
[9] |
MARANHAO RC,CARVALHO PO,STRUNZ CC,et al.Lipoprotein(a):structure,pathophysiology and clinical implications[J].Arq Bras Cardiol,2014,103(1):76. |
[10] |
GURDASANI D,SJOUKE B,TSIMIKAS S,et al.Lipoprotein(a) and risk of coronary,cerebrovascular,and peripheral artery disease:the EPIC-Norfolk prospective population study[J].Arterioscler Thromb Vasc Biol,2012,32(12):3058. |
[11] |
NESTPEL PJ,BARNES EH,TONKIN AM,et al.Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease[J].Arterioscler Thromb Vasc Biol,2013,33(12):2902. |
[12] |
ORNEK E,MURAT S,DURAN M,et al.The relationship between lipoprotein(a) and coronary artery disease,as well as its variable nature following myocardial infarction[J].Clin Invest Med,2011,34(1):14. |
[13] |
JACOBSON TA.Lipoprotein(a),cardiovascular disease and contemporary management[J].Mayo Clin Proc,2013,88(11):1294. |
[14] |
FERRARO S,MARANO G,BIGANZOLI EM,et al.Prognostic value of cystatin C in acute coronary syndromes:enhancer of atherosclerosis and promising therapeutic target[J].Clin Chem Lab Med,2011,49(9):1397. |
[15] |
KAMPOLI AM,TOUSOULIS D,PAPAGEORGIOU N.et al.Clinical utility of biomarkers in premature atherosclerosis[J].Curr Med Chem,2012,19(16):2521. |
[16] |
KIYOSUE A,HIRATA Y,ANDO J,et al.Plasma cystatin C concentration reflects the severity of coronary artery disease in patients without chronic kidney disease[J].Circ,2010,74(11):2441. |
[17] |
郭守玉,龙明智.冠心病患者胱抑素c水平与冠状动脉造影Gensini评分的相关性[J].检验医学与临床,2012,9(4):385. |
[18] |
DOGANER YC,AYDOGAN U,AYDOGDU A,et al.Relationship of cystatin C with coronary artery disease and its severity[J].Coro Artery Dis,2013,24(2):119. |
[19] |
杨曙光,汤学超.血清胱抑素c水平与冠心病严重程度的关系[J].中国动脉硬化杂志,2014,22(12):1247. |